ES2179319T3 - Acido linoleico conjugado para mantener o aumentar el contenido de minerales de los huesos. - Google Patents

Acido linoleico conjugado para mantener o aumentar el contenido de minerales de los huesos.

Info

Publication number
ES2179319T3
ES2179319T3 ES97916125T ES97916125T ES2179319T3 ES 2179319 T3 ES2179319 T3 ES 2179319T3 ES 97916125 T ES97916125 T ES 97916125T ES 97916125 T ES97916125 T ES 97916125T ES 2179319 T3 ES2179319 T3 ES 2179319T3
Authority
ES
Spain
Prior art keywords
maintain
content
increase
linoleic acid
conjugated linoleic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97916125T
Other languages
English (en)
Inventor
Mark E Cook
Michael W Pariza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wisconsin Alumni Research Foundation
Original Assignee
Wisconsin Alumni Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Research Foundation filed Critical Wisconsin Alumni Research Foundation
Application granted granted Critical
Publication of ES2179319T3 publication Critical patent/ES2179319T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Fertilizers (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE EXPONE UN PROCEDIMIENTO PARA TRATAR UN ANIMAL, A FIN DE MANTENER O AUMENTAR EL CONTENIDO DE MINERALES DE LOS HUESOS DEL ANIMAL, QUE CONSISTE EN ADMINISTRARLE UNA CANTIDAD SEGURA Y EFECTIVA DE ACIDO LINOLEICO CONJUGADO (ALC). SE EXPONEN IGUALMENTE LAS COMPOSICIONES PARA USO EN EL PROCEDIMIENTO DESCRITO.
ES97916125T 1996-08-07 1997-03-18 Acido linoleico conjugado para mantener o aumentar el contenido de minerales de los huesos. Expired - Lifetime ES2179319T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/693,577 US5804210A (en) 1996-08-07 1996-08-07 Methods of treating animals to maintain or enhance bone mineral content and compositions for use therein

Publications (1)

Publication Number Publication Date
ES2179319T3 true ES2179319T3 (es) 2003-01-16

Family

ID=24785234

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97916125T Expired - Lifetime ES2179319T3 (es) 1996-08-07 1997-03-18 Acido linoleico conjugado para mantener o aumentar el contenido de minerales de los huesos.

Country Status (9)

Country Link
US (1) US5804210A (es)
EP (1) EP0920309B1 (es)
JP (1) JP2000515864A (es)
AT (1) ATE223213T1 (es)
AU (1) AU2338497A (es)
DE (1) DE69715217T2 (es)
DK (1) DK0920309T3 (es)
ES (1) ES2179319T3 (es)
WO (1) WO1998005318A1 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2252874T3 (es) * 1997-12-12 2006-05-16 Purdue Research Foundation Utilizacion de acido linoleico conjugado para tratamiento de la diabetes mellitus tipo ii.
US7015249B1 (en) 1997-12-12 2006-03-21 Purdue Research Foundation Methods and compositions for treating diabetes
JPH11209279A (ja) * 1998-01-05 1999-08-03 Natural Ltd As 体重減少および肥満処置の方法
US6015833A (en) * 1998-03-17 2000-01-18 Conlinco., Inc. Conjugated linoleic acid compositions
US6410761B1 (en) * 1998-03-17 2002-06-25 Conlinco, Inc. Conjugated linoleic acid compositions and methods of making same
US7776353B1 (en) 1998-03-17 2010-08-17 Aker Biomarine Asa Conjugated linoleic acid compositions
US7078051B1 (en) 1998-08-11 2006-07-18 Natural Asa Conjugated linoleic acid alkyl esters in feedstuffs and food
US6077525A (en) * 1998-04-10 2000-06-20 The George Washington University Use of conjugated linoleic acids
US6214372B1 (en) 1998-05-04 2001-04-10 Con Lin Co., Inc. Method of using isomer enriched conjugated linoleic acid compositions
DE69928986T2 (de) * 1998-05-04 2006-08-24 Natural Asa Zusammensetzungen von konjugierter Linolsäure die mit Isomeren angereichert sind
US6696584B2 (en) 1998-05-04 2004-02-24 Natural Asa Isomer enriched conjugated linoleic acid compositions
US6060514A (en) 1998-05-04 2000-05-09 Conlin Co., Inc. Isomer enriched conjugated linoleic acid compositions
US7101914B2 (en) * 1998-05-04 2006-09-05 Natural Asa Isomer enriched conjugated linoleic acid compositions
US6071544A (en) * 1999-04-01 2000-06-06 The Iams Company Dietary compositions and method for promoting healthy weight loss cats
US7947737B1 (en) 1999-09-30 2011-05-24 Aker Biomarine Asa Method of treating hypertension and reducing serum lipase activity
GB0003310D0 (en) * 2000-02-15 2000-04-05 Univ Sheffield Bone formation
AU2001251449B2 (en) * 2000-04-06 2005-04-07 Conlinco, Inc. Conjugated linoleic acid compositions
US20030149288A1 (en) * 2000-04-18 2003-08-07 Natural Asa Conjugated linoleic acid powder
US6756405B2 (en) 2000-04-18 2004-06-29 Natural Asa Conjugated linoleic acid powder
US6380409B1 (en) * 2000-04-24 2002-04-30 Conlin Co., Inc. Methods for preparing CLA isomers
ES2223924T3 (es) * 2000-09-21 2005-03-01 Nutrition 21, Inc. Composiciones que contienen cromo para el tratamiento de la diabetes, la reduccion de la grasa corporal, la mejora de la sensibilidad a la insulina, la reduccion de la hiperglicemia y la reduccion de la hipercolesteremia.
BR0100421A (pt) * 2001-01-12 2002-09-10 Fundacao De Amparo A Pesquisa Produto para alimentação de mamìferos visando aumentar o teor e/ou produção de proteìna no leite, processo de obtenção de aumento de produção e/ou teor de proteìna no leite e processo de obtenção de leite que propicia maior rendimento e/ou qualidade dos produtos lácteos produzidos a partir deste leite
US6479683B1 (en) 2001-03-06 2002-11-12 Ag Processing Inc Process for conjugating fatty acid esters
US7820842B2 (en) * 2004-04-30 2010-10-26 Virtus Nutrition Llc Polyunsaturated fatty acid monovalent and divalent metal salt synthesis
US7098352B2 (en) * 2001-11-16 2006-08-29 Virtus Nutrition Llc Calcium salt saponification of polyunsaturated oils
US6677470B2 (en) 2001-11-20 2004-01-13 Natural Asa Functional acylglycerides
CA2396840A1 (en) * 2002-08-06 2004-02-06 Juan Miguel Garro Galvez New conjugated linolenic acids and methods for commercial preparation, purification and uses
US6743931B2 (en) 2002-09-24 2004-06-01 Natural Asa Conjugated linoleic acid compositions
CA2436650A1 (en) * 2003-08-06 2005-02-06 Naturia Inc. Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses
US20050154059A1 (en) * 2004-01-13 2005-07-14 Cook Mark E. Method of treating type III hypersensitive reaction-related diseases and conditions by using conjugated linoleic acid
GB201522296D0 (en) 2015-12-17 2016-02-03 Mars Inc Food product to reduce body fat

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4442125A (en) * 1978-06-26 1984-04-10 Oxford Hill, Ltd. Process for detaching or preventing attachment of microorganisms to a surface
DE3519361A1 (de) * 1985-05-30 1986-12-04 Boehringer Ingelheim International GmbH, 6507 Ingelheim (gamma)-ifn als wirkstoff zur hemmung (verhinderung) von abbauprozessen im knochen
GB8621816D0 (en) * 1986-09-10 1986-10-15 Efamol Ltd Therapeutic composition
US5017614A (en) * 1989-02-17 1991-05-21 Wisconsin Alumni Research Foundation Methods of preventing oxidation, quenching singlet oxygen and inhibiting mold growth and novel compositions therefor
US5070104A (en) * 1989-02-17 1991-12-03 Wisconsin Alumni Research Foundation Methods of chelating metal and novel compositions therefor
US5208356A (en) * 1989-02-17 1993-05-04 Wisconsin Alumni Research Foundation Octadecadienoic phospholipic esters, antioxidant and mold inhibiting compositions
GB9112052D0 (en) * 1991-06-05 1991-07-24 Efamol Holdings Fatty acid treatment
US5430066A (en) * 1992-04-29 1995-07-04 Wisconsin Alumni Research Foundation Methods for preventing weight loss, reduction in weight gain, and anorexia due to immune stimulation
US5428072A (en) * 1992-04-29 1995-06-27 Wisconsin Alumni Research Foundation Method of increasing the efficiency of feed conversion in animals
GB9217780D0 (en) * 1992-08-21 1992-10-07 Efamol Holdings Fatty acid treatment
EP0585057A1 (en) * 1992-08-25 1994-03-02 Scotia Holdings Plc Lithium salts of fatty acids for the treatment of viral infections and cancer
JP3814309B2 (ja) * 1994-04-12 2006-08-30 リポプロテイン・テクノロジーズ・インコーポレイテッド 骨粗鬆症治療剤
JPH0826982A (ja) * 1994-07-15 1996-01-30 Lion Corp 骨粗鬆症予防・治療剤
MY118354A (en) * 1995-05-01 2004-10-30 Scarista Ltd 1,3-propane diol derivatives as bioactive compounds

Also Published As

Publication number Publication date
DK0920309T3 (da) 2002-12-09
DE69715217D1 (de) 2002-10-10
DE69715217T2 (de) 2003-08-07
US5804210A (en) 1998-09-08
ATE223213T1 (de) 2002-09-15
EP0920309B1 (en) 2002-09-04
EP0920309A1 (en) 1999-06-09
JP2000515864A (ja) 2000-11-28
WO1998005318A1 (en) 1998-02-12
AU2338497A (en) 1998-02-25

Similar Documents

Publication Publication Date Title
ES2179319T3 (es) Acido linoleico conjugado para mantener o aumentar el contenido de minerales de los huesos.
ATE281160T1 (de) Verfahren zur erhaltung von bestehenden körperfettgehalt und/oder körpergewicht
ES2186898T3 (es) Metodos para evitar problemas de esqueleto en aves de corral.
BR9916879A (pt) Composição e método para tratamento do câncer utilizando óleos essenciais vegetais naturais
ATE286392T1 (de) Photodynamische behandlung von synovium
ID23496A (id) Ekstrak tanaman untuk mengobati peningkatan resorpsi tulang
AR023130A1 (es) Composiciones para promover el crecimiento
BR9205983A (pt) Suplementos de cálcio e vitamina d combinados
MY109928A (en) Fatty acid treatment
ES2069750T3 (es) Metodos y composiciones para curar huesos.
BR9810121A (pt) Utilização do acido petroselìnico nativo ou esterificado
IL74617A (en) Compositions comprising a vitamin d derivative and method for the local treatment of bone fractures in animals
PT777482E (pt) Composicao de combinacao para utilizacao em doencas imunologicas
NZ333724A (en) Enhancing lean tissue mass and bone mineral content by the administration of calcium compositions
DE69232287D1 (de) Verfahren und zusammensetzung zur verminderung von reperfusionsschäden des myokards
PT2009025E (pt) Método de inibição da actividade dos osteoclastos
DE69825279D1 (de) Verwendung von glukosamin und glukosaminderivaten zur schnellen linderung von juckreiz oder lokalisiertem schmerz
BR8304987A (pt) Composicao microbiocida,metodo para controlar microorganismos vivos em um sistema aquosos e metodo de proteger isotiazolonas microbiocidas
ATE210989T1 (de) Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung
ZA837972B (en) Method of analgesic treatment and pharmaceutical compositions
GB9823307D0 (en) Composition for traetment of periodontopathy and related diseases
BR9612549A (pt) Método para tratamento de agressão excessiva
BR9709007A (pt) Uso de azaspirano substituìdo no tratamento da asma.
ID23210A (id) Komposisi sinergistik dan metoda untuk pengobatan neoplastik atau pertumbuhan kanker dan untuk memperbaiki atau meningkatkan hematopoiesis
ES515430A0 (es) Procedimiento y disposicion correspondiente de implantacion de clavos o pernos para el tratamiento de fracturas de cuello de femur en humanos.